These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases. Boschetti G, Nancey S, Sardi F, Roblin X, Flourié B, Kaiserlian D. Inflamm Bowel Dis; 2011 Jan; 17(1):160-70. PubMed ID: 20848510 [Abstract] [Full Text] [Related]
5. Restoration of Foxp3+ Regulatory T-cell Subsets and Foxp3- Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases During Anti-tumor Necrosis Factor Therapy. Li Z, Vermeire S, Bullens D, Ferrante M, Van Steen K, Noman M, Rutgeerts P, Ceuppens JL, Van Assche G. Inflamm Bowel Dis; 2015 Oct; 21(10):2418-28. PubMed ID: 26308438 [Abstract] [Full Text] [Related]
9. Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn's disease. Juanola O, Moratalla A, Gutiérrez A, Sempere L, Zapater P, Giménez P, Almenta I, Peiró G, González-Navajas JM, Such JF, Francés R. J Gastroenterol; 2015 Jul; 50(7):758-68. PubMed ID: 25500977 [Abstract] [Full Text] [Related]
10. Biosimilar infliximab (CT-P13) in the treatment of inflammatory bowel disease: A Norwegian observational study. Jahnsen J, Detlie TE, Vatn S, Ricanek P. Expert Rev Gastroenterol Hepatol; 2015 Jul; 9 Suppl 1():45-52. PubMed ID: 26395534 [Abstract] [Full Text] [Related]
11. Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy. Caprioli F, Bosè F, Rossi RL, Petti L, Viganò C, Ciafardini C, Raeli L, Basilisco G, Ferrero S, Pagani M, Conte D, Altomare G, Monteleone G, Abrignani S, Reali E. Inflamm Bowel Dis; 2013 Jul; 19(4):729-39. PubMed ID: 23448791 [Abstract] [Full Text] [Related]
12. Modulation of CD39 and Exogenous APT102 Correct Immune Dysfunction in Experimental Colitis and Crohn's Disease. Robles RJ, Mukherjee S, Vuerich M, Xie A, Harshe R, Cowan PJ, Csizmadia E, Wu Y, Moss AC, Chen R, Robson SC, Longhi MS. J Crohns Colitis; 2020 Jul 09; 14(6):818-830. PubMed ID: 31693091 [Abstract] [Full Text] [Related]